Deanna Pratt
Psychiatric/Mental Health · Prestonsburg, KYNPI 1730799560
Payments from drug & device makers
Across 365 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$851
- Alkermes, Inc.$724
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$687
- Lundbeck LLC$588
- Vanda Pharmaceuticals Inc.$524
- Teva Pharmaceuticals USA, Inc.$438
- plus $2K from 12 others
What the payments were for
- Food & beverage$5,80899%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $851 |
| Alkermes, Inc. | 46 | $724 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 45 | $687 |
| Lundbeck LLC | 36 | $588 |
| Vanda Pharmaceuticals Inc. | 25 | $524 |
| Teva Pharmaceuticals USA, Inc. | 26 | $438 |
| Johnson & Johnson | 23 | $411 |
| Indivior Inc. | 25 | $403 |
| Otsuka America Pharmaceutical, Inc. | 19 | $379 |
| Neurocrine Biosciences, Inc. | 20 | $328 |
| E.r. Squibb & Sons, L.L.C. | 11 | $143 |
| Axsome Therapeutics, Inc. | 8 | $140 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $73 |
| Corium, LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Eisai Inc. | 2 | $31 |
| Braeburn Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$5,855 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $93,189 |
| RexultiBrexpiprazole | 30 | $43,093 |
| VraylarCariprazine Hcl | 21 | $29,438 |
| Risperdal ConstaRisperidone Microspheres | 13 | $21,795 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 296 | $13,497 |
| MounjaroTirzepatide | 12 | $12,063 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,422 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 45 | $925 |
| Buspirone Hcl | 67 | $820 |
| Hydroxyzine Pamoate | 47 | $731 |
| Duloxetine Hcl | 40 | $431 |
| Hydroxyzine Hcl | 22 | $309 |
| Quetiapine Fumarate | 34 | $284 |
| Amitriptyline Hcl | 35 | $252 |
| Bupropion XlBupropion Hcl | 18 | $216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $328 | $93,18911 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $379 | $43,09330 claims |
| AbbVieVraylar | $851 | $29,43821 claims |
| Johnson & JohnsonRisperdal Consta | $411 | $21,79513 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $48 | $5,42211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Prestonsburg
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
- Davika MattoxMorehead$79K
- Molly LutzCrestview Hills$71K
- Hope SmithHopkinsville$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.